Publications found:
73
Sort by:
Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2023
US$ 3,995.00
... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...
September 2023
350 pages
Collaboration Deals in Pharmaceuticals 2019-2023
US$ 3,995.00
... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...
September 2023
1000 pages
Distribution Deals in Pharmaceuticals and Biotechnology 2016 to 2023
US$ 3,995.00
... DESCRIPTION The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and ...
September 2023
500 pages
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2023
US$ 3,995.00
... Joint venture alliances. KEY BENEFITS Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 provides the reader with the following key benefits: In-depth understanding of joint venture partnering deal ...
September 2023
200 pages
Licensing Deals in Pharmaceuticals 2019-2023
US$ 3,995.00
... latest licensing agreements announced in the pharmaceutical, biotechnology ... licensing deals by value since 2014 Most active licensing dealmakers since 2014 The leading licensing partnering resources In Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 available deals ...
September 2023
1200 pages
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2023
US$ 3,995.00
... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...
September 2023
700 pages
Royalty Rates in Pharmaceuticals and Biotechnology Deals
US$ 3,995.00
... including the technology licensed, royalty rates, license fees, upfront and milestone payments. DESCRIPTION The Global Royalty Rate Trends in Pharma ... licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering deals which disclose a royalty rate ...
September 2023
500 pages
Collaboration Deals in Biotechnology 2019-2023
US$ 3,995.00
SUMMARY Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2023 DESCRIPTION Collab...
September 2023
1000 pages
Distribution Deals in Diagnostics 2016 to 2023
US$ 3,995.00
SUMMARY Distribution Deals in Diagnostics | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2023 DESCRIPTION Distribut...
September 2023
250 pages
Licensing Deals in Biotechnology 2019-2023
US$ 3,995.00
SUMMARY Licensing Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2023Licensing Deals in Biot...
September 2023
1000 pages
Distribution Deals in Medical Devices 2016 to 2023
US$ 3,995.00
SUMMARY Distribution Deals in Medical Devices | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2023 DESCRIPTION Distr...
September 2023
250 pages
Global Bioinformatics Partnering Terms and Agreements 2016 to 2023
US$ 3,995.00
... companies. Trends in bioinformatics partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active deal makers Financial deal terms for bioinformatics The Global Bioinformatics Partnering Terms and Agreements 2014 ...
June 2023
800 pages
Global Oncology Partnering 2016-2023: Deal trends, players and financials
US$ 3,995.00
... , Vomiting, Chemotherapy, Radiotherapy, Adenocarcinoma, Basal cell carcinoma, Bile duct cancer, Bladder cancer, Bone cancer, Brain cancer, Breast cancer, Cervical cancer, Colorectal cancer, Endometrial, Esophageal cancer, Gastric cancer, Head and neck cancer, Kaposi's sarcoma, Kidney cancer, Leukemia, Acute ...
June 2023
3500 pages
Global Regenerative Medicine Partnering Terms and Agreements 2016 to 2023
US$ 3,995.00
... access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies. DESCRIPTION The Global Regenerative Medicine Partnering 2014-2019: Deal trends, players ...
June 2023
1000 pages
Global Monoclonal Antibody Partnering Terms and Agreements 2016 to 2023
US$ 3,995.00
... Access to over 640 monoclonal antibodies deal records The leading monoclonal antibodies deals by value since 2014 Includes chimeric mAb, humanized mAb, human mAb and murine mAb deals and alliances since 2014 In Global Monoclonal antibody Partnering Terms and Agreements 2014 to 2098 ...
June 2023
650 pages
Global Diagnostic Imaging Partnering Terms and Agreements 2016 to 2023
US$ 3,995.00
... imaging partnering deals. This report provides details of the latest diagnostics agreements announced in the healthcare sectors, covering: Imaging CT Endoscope Molecular and nuclear PET SPECT MRI Ultrasound X ray Angiography Fluoroscopy Mammography This report provides an overview of diagnostic imaging ...
June 2023
500 pages
Global Gene Therapy Partnering Terms and Agreements 2010 to 2023
US$ 3,995.00
... -life gene therapy deals Access to over 220 gene therapy deals The leading gene therapy deals by value since 2014 Most active gene therapy dealmakers since 2014 The leading gene therapy partnering resources In Global Gene Therapy Partnering Terms and ...
June 2023
550 pages
Global Genomics Partnering Terms and Agreements 2016 to 2023
US$ 3,995.00
... , upfronts, milestones and royalties by stage of development Genomics partnering contract documents Top Genomics deals by value The Global Genomics Partnering Terms and Agreements report provides an understanding and ...
June 2023
450 pages
Global Microbiome Partnering Terms and Agreements 2010 to 2023
US$ 3,995.00
... , upfronts, milestones and royalties by stage of development Microbiome partnering contract documents Top Microbiome deals by value The Global Microbiome Partnering Terms and Agreements report provides an understanding and ...
June 2023
250 pages
Global Proteomics Partnering Terms and Agreements 2010 to 2023
US$ 3,995.00
... , upfronts, milestones and royalties by stage of development Proteomics partnering contract documents Top Proteomics deals by value The Global Proteomics Partnering Terms and Agreements report provides an understanding and ...
June 2023
400 pages
Global Companion Diagnostics Partnering Terms and Agreements 2010-2023
US$ 3,995.00
... Case studies of real-life Companion Diagnostics deals Access to Companion Diagnostics contract documents Leading Companion Diagnostics deals by value since 2014 Most active Companion Diagnostics dealmakers since 2014 In Global Companion Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...
May 2023
350 pages
Global Cancer Vaccine Partnering Terms and Agreements 2010-2023
US$ 3,995.00
... Case studies of real-life Cancer Vaccine deals Access to Cancer Vaccine contract documents Leading Cancer Vaccine deals by value since 2014 Most active Cancer Vaccine dealmakers since 2014 In Global Cancer Vaccine Partnering 2014-2019: Deal trends, players, financials and ...
May 2023
250 pages
Global Antibody Partnering Terms and Agreements 2016-2023
US$ 3,995.00
... announced in the healthcare sectors, covering: Antibodies Antibody-drug conjugates Monoclonal antibodies Murine mAb Chimeric mAb Humanized mAb Human aAb Polyclonal Antibodies Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process ...
May 2023
1100 pages
Global Antibiotics Partnering Terms and Agreements 2010 to 2023
US$ 3,995.00
... healthcare sectors, covering: Antibiotics Aminoglycosides Cephalosporin Clindamycin Macrolides Penicillin Quinolones Sulfonamides Tetracycline Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into ...
May 2023
300 pages
Global Cancer Diagnostics Partnering Terms and Agreements 2016-2023
US$ 3,995.00
... Case studies of real-life Cancer Diagnostics deals Access to Cancer Diagnostics contract documents Leading Cancer Diagnostics deals by value since 2014 Most active Cancer Diagnostics dealmakers since 2014 In Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...
May 2023
550 pages
Global Orphan Diseases Partnering 2010-2023: Deal trends, players and financials
US$ 3,995.00
... to hundreds of Orphan Diseases deal contract documents Comprehensive access to over 120 Orphan Diseases deal records The leading Orphan Diseases deals by value since 2014 Most active Orphan Diseases dealmakers since 2014 In Global Orphan Diseases Partnering 2014 to 2019, available deals and ...
May 2023
200 pages
Global Diagnostics Partnering Terms and Agreements 2016-2023
US$ 3,995.00
... healthcare sectors, covering: Companion Diagnostics Imaging CT Endoscope Molecular and nuclear MRI Ultrasound X-ray PET SPECT Angiography Fluroscopy Mammography In vitro diagnostics Molecular diagnostics Prognostics Theranostics The report provides a detailed ...
May 2023
1500 pages
Global Drug delivery Partnering Terms and Agreements 2016-2023
US$ 3,995.00
... Drug Delivery deals Access to Drug Delivery contract documents Leading Drug Delivery deals by value since 2014 Most active Drug Delivery dealmakers since 2014 In Global Drug Delivery Partnering 2014-2019: Deal ... at signing Deal component type Specific therapy target Technology type Each deal title links ...
May 2023
900 pages
Global In Vitro Diagnostics Partnering Terms and Agreements 2010-2023
US$ 3,995.00
... of real-life In Vitro Diagnostics deals Access to In Vitro Diagnostics contract documents Leading In Vitro Diagnostics deals by value since 2014 Most active In Vitro Diagnostics dealmakers since 2014 In Global In Vitro Diagnostics Partnering 2014-2019: Deal trends, players ...
May 2023
550 pages
Global Stem Cell Partnering Terms and Agreements 2010-2023
US$ 3,995.00
... Case studies of real-life Stem Cell deals Access to Stem Cell contract documents Leading Stem Cell deals by value since 2014 Most active Stem Cell dealmakers since 2014 In Global Stem Cell Partnering 2014-2019: Deal trends, players, financials and ...
May 2023
450 pages
Global Precision Medicine Partnering Terms and Agreements 2016-2023
US$ 3,995.00
... unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies DESCRIPTION The Global Precision Medicine Partnering 2014-2019 report provides comprehensive understanding ...
May 2023
1000 pages